呼吸道感染应用不同喹诺酮类药物的治疗的疗效对比分析

目的:探讨不同喹诺酮类药物在呼吸道感染中的应用价值。方法:选择本院2015年4月-2017年9月接诊的呼吸道感染病患200例,将之利用随机数表法分成甲、乙、丙、丁、戊5组,每组40例。对甲组施以莫西沙星治疗,对乙组施以左氧氟沙星治疗,对丙组施以环丙沙星治疗,对丁组施以依诺沙星治疗,对戊组施以帕珠沙星治疗。综合分析各组的临床疗效,并对其性价比等指标作出比较。结果:各组疗效总有效率以及不良反应发生率比较无显著差异,P<0.05。在5种药物当中,左氧氟沙星的性价比最高。结论:于呼吸道感染中积极应用左氧氟沙星,安全可靠,成本低,值得临床借鉴。

Objective:To explore the application value of different quinolones in respiratory tract infection.Methods:200 cases of patients in our hospital in April 2015-2017 year in September,the respiratory tract infection,will use the random number table method is divided into a,B,C,D,e 5 group,40 cases in each group.The group with moxifloxacin,levofloxacin in the treatment of with group B,group C with ciprofloxacin in the treatment of,with Enoxacin in the treatment of group D,e group of treatment with pazufloxacin.The clinical efficacy of each group was analyzed,and the performance ratio was compared.Results:There was no significant difference in the total effective efficiency and the incidence of adverse reactions in each group,P<0.05.Of the 5 drugs,levofloxacin was the most cost-effective.Conclusion:The active application of levofloxacin in respiratory tract infection is safe and reliable,and the cost is low.It is worthy of clinical reference.